Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Yehuda HandelsmanStacey L Abby

Abstract

To assess the effect of the bile acid sequestrant colesevelam hydrochloride in patients with hypercholesterolemia and prediabetes. In this 16-week, randomized, double-blind study, adults with untreated prediabetes (2-hour postoral glucose tolerance test [OGTT] glucose > or =140 to 199 mg/dL, fasting plasma glucose [FPG] > or =110 to 125 mg/dL, or both), low-density lipoprotein cholesterol (LDL-C) > or =100 mg/dL, and triglycerides <500 mg/dL were randomly assigned to receive colesevelam (3.75 g/d) or placebo. The primary end point was percent change in LDL-C from baseline to week 16 with last observation carried forward. Secondary end points included change in FPG, hemoglobin A1c (A1C), and 2-hour post-OGTT glucose level from baseline to week 16 and attainment of LDL-C and FPG targets. In total, 216 patients were randomized (colesevelam, 108; placebo, 108). In comparison with placebo, colesevelam significantly reduced LDL-C (mean treatment difference, -15.6%), non-high-density lipoprotein cholesterol (-9.1%), total cholesterol (-7.2%), apolipoprotein B (-8.1%) (P<.001 for all the foregoing), FPG (median, -2.0 mg/dL; P = .02), and A1C (mean, -0.10%; P = .02). Colesevelam did not significantly change 2-hour post-OGTT glucose (-1....Continue Reading

References

May 10, 2001·JAMA : the Journal of the American Medical Association·F de VegtR J Heine
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Jun 28, 2002·Lancet·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trail Research Group
Jul 24, 2003·JAMA : the Journal of the American Medical Association·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trial Research Group
Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Mar 29, 2005·Diabetes Care·Robert RatnerUNKNOWN Diabetes Prevention Program Research Group
Aug 23, 2006·The American Journal of Cardiology·Sridevi DevarajIshwarlal Jialal
Nov 23, 2006·Lancet·Roger Williams
Jul 25, 2007·Archives of Internal Medicine·Elizabeth SelvinJosef Coresh
Jan 22, 2008·Journal of the American College of Cardiology·Yamini S LevitzkyCaroline S Fox
Nov 11, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberRichard W Nesto
Nov 27, 2009·Postgraduate Medicine·Yehuda HandelsmanMichael R Jones
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Oct 16, 2010·Metabolic Syndrome and Related Disorders·Philip Levy
Mar 19, 2013·Metabolic Syndrome and Related Disorders·Dana Sheely, Ishwarlal Jialal
Dec 22, 2011·Current Opinion in Lipidology·Carolien OutGemma Brufau
May 3, 2012·Journal of Lipid Research·Geoffrey PorezBart Staels
Apr 16, 2014·Trends in Endocrinology and Metabolism : TEM·Janne PrawittBart Staels
Mar 22, 2012·Expert Opinion on Drug Metabolism & Toxicology·Lisa M Younk, Stephen N Davis
Aug 5, 2011·The American Journal of Cardiology·Gloria Lena VegaScott M Grundy
May 6, 2011·Diabetes Care·Yehuda Handelsman
Aug 5, 2011·Journal of Pharmacy Practice·Luigi Brunetti, R Keith Campbell
Mar 18, 2017·Diabetes, Obesity & Metabolism·Martin L KårhusFillip K Knop
Apr 25, 2014·European Journal of Endocrinology·David P SonneFilip K Knop
Jun 6, 2015·Circulation. Cardiovascular Genetics·Stephanie RossGuillaume Paré
Nov 16, 2012·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Ronald B GoldbergMichael R Jones
Aug 24, 2012·Postgraduate Medicine·Julio RosenstockMichael R Jones
Jan 28, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·Quan ShangGuorong Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.